Evidence map›Paper›PMID 28087910›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2016

[Progress on anti-tumor molecular mechanisms of dihydroartemisinin].

Peng Cao, Dongjin Leng, Ying Li, Ziwei Zhang, Lei Liu, Xiaoyan Li

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. The Evaluation ofMolecular imaging and biology · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Peng CaoCollege of Life Science, Northeast Forest University, Harbin 150040, China.
Dongjin LengCollege of Life Science, Northeast Forest University, Harbin 150040, China.
Ying LiCollege of Life Science, Northeast Forest University, Harbin 150040, China.
Ziwei ZhangCollege of Life Science, Northeast Forest University, Harbin 150040, China.
Lei LiuCollege of Life Science, Northeast Forest University, Harbin 150040, China.
Xiaoyan LiCollege of Life Science, Northeast Forest University, Harbin 150040, China. xyli821187@163.com.
Northeast Forestry University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artemisinin is an anti-malarial drug with poor water solubility and oral absorption; so a variety of derivatives based on the parent nucleus have been developed. Compared with artemisinin, dihydroartemisinin (DHA) has a stronger anti-malaria activity, and has the advantages of high metabolic rate and better water solubility. Recent studies have discovered that DHA has a good inhibitory effect on tumor cells, which is closely related to the peroxide bridge in its molecular structure. Since tumor cells need more Fe

Indexed as

Antigens, CDAntineoplastic AgentsApoptosisArtemisininsEndocytosisFree RadicalsHumansIronNeoplasmsOxidative StressReceptors, TransferrinAntigens, CDAntineoplastic AgentsArtemisininsartenimolCD71 antigenFree RadicalsIronReceptors, Transferrin

Identifiers

PMID28087910
PMCPMC10397050
OpenAlexW2746481294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.